NCT03573583

Brief Summary

The pilot study is to assess the feasibility of using a new method to measure muscle mass called Deuterated Creatine (D3Cr) method and thereby understand the role of muscle mass on functional outcomes in older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 29, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

July 3, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

1.5 years

First QC Date

June 5, 2018

Results QC Date

April 29, 2024

Last Update Submit

June 10, 2024

Conditions

Keywords

muscle massmuscle lossDeuterated creatine (D3Cr) dilutionolder adultsresistance trainingphysical function

Outcome Measures

Primary Outcomes (1)

  • Muscle Mass

    Change in Muscle mass measured using D3Cr

    Baseline and week 16

Secondary Outcomes (3)

  • Appendicular Lean Mass (ALM)

    Baseline and week 16

  • Lean Body Mass (LBM)

    Baseline, and Week 16

  • Correlation Between Changes in Muscle Mass

    Baseline and Week 15

Study Arms (2)

Resistance Training group (RT)

EXPERIMENTAL

The resistance training intervention will include a full body, resistance training performed three days per week.The intensity, volume, tempo, and progression will be based on the Federal Physical Activity guidelines

Behavioral: Resistance Training

Successful Aging

ACTIVE COMPARATOR

The comparator group will meet for stretching and health education classes every 2-5 weeks up to 7 total visits.

Behavioral: Successful Aging

Interventions

The intensity, volume, tempo, and progression will be based on the Federal Physical Activity guidelines. The resistance training exercises will include mainly multi-joint exercises using selectorized machines. Each session will include upper body exercises (Chest Press, Shoulder Press, Seated Rows, Bicep curls, and Tricep Extensions) and lower body exercises (Leg Press, Leg Extension and Leg Curls, and Calf raise) that will be tailored to the participant needs.

Also known as: RT, Strength Training, Weight Training
Resistance Training group (RT)

The successful aging will attend stretching and health lectures as a group . The topics might include, medication management, disease management (e.g. blood pressure, diabetes, arthritis, dementia, pain management, diet) and other health related matters.

Also known as: HE, Health Education
Successful Aging

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • men and women aged 70 or greater
  • at high risk for mobility disability based on lower extremity functional limitations measured by Short Physical Performance battery (SPPB) with a score ≤ 8 out of 12
  • could safely participate in the resistance training intervention as determined by medical history and physical examination.
  • willing to give informed consent to be randomized to either the resistance training group or successful aging heath education comparison group and willing to follow the study protocol

You may not qualify if:

  • Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
  • Myocardial infarction, major heart surgery, stroke, deep vein thrombosis, or pulmonary embolus in the past 6 months
  • Lung disease requiring either oral or injected steroids, or the use of supplemental oxygen
  • Short, portable mental status questionnaire with 3 or more errors
  • Severe arthritis (either osteoarthritis or rheumatoid arthritis) that severely limits mobility
  • Severe lower back or shoulder pain that can worsen with weight lifting exercises.
  • Cancer requiring treatment in the past 1 year (Melanomas excluded)
  • Any present or recent history of severe psychiatric illness including depression that might preclude providing informed consent, safe participation, or compliance (self-report and investigator judgement
  • Development of chest pain or severe shortness of breath on the 400 m self-paced walk test
  • Parkinson's disease or other serious neurological disorders; renal disease requiring dialysis; other illness of such severity that life expectancy is considered to be less than 12 months
  • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  • Current consumption of more than 14 alcoholic drinks per week
  • Uncontrolled hypertension (systolic blood pressure \> 200 mm Hg and/or diastolic blood pressure \>110 mm Hg)
  • Currently on testosterone, Dehydroepiandrosterone (DHEA), or anabolic steroids.
  • Undergoing physical therapy involving the lower extremities
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UF Health at the University of Florida

Gainesville, Florida, 32610, United States

Location

UF Institute on Aging Clinical and Translational Research Building

Gainesville, Florida, 32611, United States

Location

Related Publications (1)

  • Balachandran AT, Evans WJ, Cawthon PM, Wang Y, Shankaran M, Hellerstein MK, Qiu P, Manini T. Comparing D3-Creatine Dilution and Dual-Energy X-ray Absorptiometry Muscle Mass Responses to Strength Training in Low-Functioning Older Adults. J Gerontol A Biol Sci Med Sci. 2023 Aug 27;78(9):1591-1596. doi: 10.1093/gerona/glad047.

MeSH Terms

Conditions

SarcopeniaMuscular Atrophy

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

Our study has several limitations. First, the sample size was relatively small. Clearly, the study needs to be replicated with a larger sample to make definitive statements. Although it is considered a strength in some respects, the results are only applicable to low-functioning older adults. Additional measures of body composition were not included, but would have allowed additional comparisons (eg, whole-body MRI or a 4-compartment model) with D3Cr.

Results Point of Contact

Title
Todd Manini
Organization
University of Florida

Study Officials

  • Todd Manini, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
To ensure concealment of the allocation, the randomization procedures will be performed by an investigator who are not involved in the assessments. The team assessing study outcomes will be masked to intervention assignment.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: The pilot study will be single-blind, parallel group, randomized controlled trial of 24 moderate to low functioning participants randomized in a 1:1 allocation ratio to a high-intensity Resistance Training group (RT) or a Successful Aging Health Education comparator group (HE) for 14 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2018

First Posted

June 29, 2018

Study Start

February 1, 2019

Primary Completion

August 1, 2020

Study Completion

August 1, 2020

Last Updated

July 3, 2024

Results First Posted

July 3, 2024

Record last verified: 2024-06

Locations